Dr Hamid on the Investigation of Fianlimab With Cemiplimab in Advanced Melanoma
Omid Hamid, MD, discusses the investigation of the LAG-3 inhibitor fianlimab in combination with cemiplimab in patients with advanced melanoma who were naïve to anti–PD-1 agents in the advanced setting.